FDA授予iRegene公司NouvNeu001再生医学先进疗法认定,巩固其作为全球首个同时获得FTD与RMAT认证的iPSC疗法的领先地位。
FDA Grants RMAT Designation to iRegene’s NouvNeu001, Cementing its Lead as the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
生物技术与制药领域的最新动态
FDA Grants RMAT Designation to iRegene’s NouvNeu001, Cementing its Lead as the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
AstraZeneca pens $630M pact to secure remaining rights to armored CAR-T from AbelZeta
Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis - Yahoo Finance
The Zacks Analyst Blog Highlights Visa, Advanced Micro Devices and Thermo Fisher Scientific - Zacks Investment Research
Zincure synthesizes new MMP-9 inhibitors
Chong Kun Dang Pharmaceutical discovers new GLP-1R agonists
Negio Therapeutics patents α2-adrenoceptor agonists
Nanjing Chia Tai Tianqing Pharmaceutical identifies new somatostatin SST2 receptor agonists
Shenzhen Newrosetta Biosciences discloses new muscarinic M2 receptor antagonists
Cathie Wood's weekly update: buys Broadcom, AMD; sells Tesla, Illumina - MSN
Immunology biotech Agomab, eye-focused SpyGlass are latest biotechs to share IPO ambitions
Gas Chromatography Systems Market to Reach US$ US$7,203.59 - openPR.com
Oncology Research Solutions - Illumina
A high-resolution analysis of arrestin2 interactions responsible for CCR5 endocytosis
Predicting human decision-making across task conditions via individuality transfer
Linking neuron-glia interactions and longevity
Did 10x Genomics’ (TXG) Clinical Collaborations and CLIA Push Just Recast Its Investment Narrative? - simplywall.st
Aug Ideas: Can 10x Genomics Inc stock outperform in a bear market - July 2025 Closing Moves & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Agilent Technologies, Inc. $A Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Agilent Technologies, Inc. $A Shares Acquired by Lmcg Investments LLC - MarketBeat